drug
Sodium phenylbutyrate Navinta
Marketedupdated 3mo agoby Navinta LLC
Approvedcommunity read0 votes
🐶 often sniffed alongside
top 6all catalysts(0)
nothing on the calendar yet
Trials studying Sodium phenylbutyrate Navinta
- phase2Study of Sodium Phenylbutyrate (ACER-001) for the Treatment of Pediatric and Adults Patients With Medium Chain Acyl-CoA Dehydrogenase Deficiency (MCADD)
- phase2Study of Sodium Phenylbutyrate (ACER-001) for the Treatment of Patients With Medium Chain Acyl-CoA Dehydrogenase Deficiency (MCADD)
- phase1An Individual Patient, Open Label Study to Use ACER-001 to Treat Combined D,L-2 Hydroxyglutaric Aciduria (C-2HGA)
News(0)
no news has mentioned this drug yet
Data sources
last refreshed 47m ago
Found something off?
comments(0)
5-min edit window · permanent after that